About Cytokinetics Inc.
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Market Cap
$5.13B
Employees
564
Listed Since
April 29, 2004
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.cytokinetics.comPhone
(650) 624-3000
Headquarters
350 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
CIK
0001061983